{"address1": "238 Main Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 327 8775", "website": "https://beamtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 393, "companyOfficers": [{"maxAge": 1, "name": "Mr. John M. Evans M.B.A.", "age": 46, "title": "CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1234010, "exercisedValue": 0, "unexercisedValue": 16127756}, {"maxAge": 1, "name": "Dr. Giuseppe  Ciaramella Ph.D.", "age": 55, "title": "President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1041270, "exercisedValue": 2506545, "unexercisedValue": 5912415}, {"maxAge": 1, "name": "Mr. Sravan Kumar Emany", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 617074, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christine P. Bellon J.D., Ph.D.", "age": 58, "title": "Senior VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 744950, "exercisedValue": 0, "unexercisedValue": 363849}, {"maxAge": 1, "name": "Dr. Amy  Simon M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 779170, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Feng  Zhang Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David R. Liu Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J. Keith Joung M.D., Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Manmohan  Singh Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gopi  Shanker Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.75, "open": 17.42, "dayLow": 16.94, "dayHigh": 17.78, "regularMarketPreviousClose": 17.75, "regularMarketOpen": 17.42, "regularMarketDayLow": 16.94, "regularMarketDayHigh": 17.78, "payoutRatio": 0.0, "beta": 2.348, "forwardPE": -3.6100628, "volume": 1828432, "regularMarketVolume": 1828432, "averageVolume": 2407295, "averageVolume10days": 1917190, "averageDailyVolume10Day": 1917190, "bid": 17.14, "ask": 17.31, "bidSize": 2, "askSize": 3, "marketCap": 1731591424, "fiftyTwoWeekLow": 13.525, "fiftyTwoWeekHigh": 35.25, "priceToSalesTrailing12Months": 27.2357, "fiftyDayAverage": 19.4476, "twoHundredDayAverage": 24.2599, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 668557248, "profitMargins": 0.0, "floatShares": 86266522, "sharesOutstanding": 100557000, "sharesShort": 19260565, "sharesShortPriorMonth": 14739307, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.1915, "heldPercentInsiders": 0.01224, "heldPercentInstitutions": 0.97955, "shortRatio": 6.75, "shortPercentOfFloat": 0.21540001, "impliedSharesOutstanding": 100557000, "bookValue": 11.521, "priceToBook": 1.4946619, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -387343008, "trailingEps": -4.61, "forwardEps": -4.77, "enterpriseToRevenue": 10.516, "enterpriseToEbitda": -1.636, "52WeekChange": -0.28657556, "SandP52WeekChange": 0.11936104, "quoteType": "EQUITY", "currentPrice": 17.22, "targetHighPrice": 80.0, "targetLowPrice": 20.0, "targetMeanPrice": 44.4, "targetMedianPrice": 42.0, "recommendationMean": 1.58824, "recommendationKey": "buy", "numberOfAnalystOpinions": 15, "totalCash": 1219952000, "totalCashPerShare": 12.514, "ebitda": -408700000, "totalDebt": 158128992, "quickRatio": 8.619, "currentRatio": 8.814, "totalRevenue": 63578000, "debtToEquity": 14.079, "revenuePerShare": 0.758, "returnOnAssets": -0.19047001, "returnOnEquity": -0.38037997, "grossProfits": -302071008, "freeCashflow": -185897248, "operatingCashflow": -351383008, "revenueGrowth": 0.008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.96867, "financialCurrency": "USD", "symbol": "BEAM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1747857846, "regularMarketTime": 1747857601, "fiftyTwoWeekChangePercent": -28.657555, "earningsTimestamp": 1746529200, "earningsTimestampStart": 1754310600, "earningsTimestampEnd": 1754656200, "earningsCallTimestampStart": 1730813400, "earningsCallTimestampEnd": 1730813400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.61, "epsForward": -4.77, "epsCurrentYear": -4.54372, "priceEpsCurrentYear": -3.7898462, "fiftyDayAverageChange": -2.2276, "fiftyDayAverageChangePercent": -0.114543706, "twoHundredDayAverageChange": -7.0399, "twoHundredDayAverageChangePercent": -0.2901867, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "shortName": "Beam Therapeutics Inc.", "longName": "Beam Therapeutics Inc.", "regularMarketChangePercent": -2.9859195, "regularMarketPrice": 17.22, "marketState": "POST", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580999400000, "postMarketChangePercent": 0.0, "postMarketPrice": 17.22, "postMarketChange": 0.0, "regularMarketChange": -0.5300007, "regularMarketDayRange": "16.94 - 17.78", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2407295, "fiftyTwoWeekLowChange": 3.6949997, "fiftyTwoWeekLowChangePercent": 0.27319777, "fiftyTwoWeekRange": "13.525 - 35.25", "fiftyTwoWeekHighChange": -18.03, "fiftyTwoWeekHighChangePercent": -0.5114894, "exchange": "NMS", "messageBoardId": "finmb_564610577", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Beam Therapeutics", "trailingPegRatio": null}